133 related articles for article (PubMed ID: 17428679)
21. Regulation of the PML tumor suppressor in drug-induced senescence of human normal and cancer cells by JAK/STAT-mediated signaling.
Hubackova S; Novakova Z; Krejcikova K; Kosar M; Dobrovolna J; Duskova P; Hanzlikova H; Vancurova M; Barath P; Bartek J; Hodny Z
Cell Cycle; 2010 Aug; 9(15):3085-99. PubMed ID: 20699642
[TBL] [Abstract][Full Text] [Related]
22. Direct transcriptional activation of promyelocytic leukemia protein by IFN regulatory factor 3 induces the p53-dependent growth inhibition of cancer cells.
Kim TK; Lee JS; Oh SY; Jin X; Choi YJ; Lee TH; Lee Eh; Choi YK; You S; Chung YG; Lee JB; DePinho RA; Chin L; Kim H
Cancer Res; 2007 Dec; 67(23):11133-40. PubMed ID: 18056437
[TBL] [Abstract][Full Text] [Related]
23. p14ARF induces the relocation of HDM2 and p53 to extranucleolar sites that are targeted by PML bodies and proteasomes.
Kashuba E; Mattsson K; Klein G; Szekely L
Mol Cancer; 2003 Mar; 2():18. PubMed ID: 12685933
[TBL] [Abstract][Full Text] [Related]
24. Promyelocytic leukemia nuclear bodies are predetermined processing sites for damaged DNA.
Bøe SO; Haave M; Jul-Larsen A; Grudic A; Bjerkvig R; Lønning PE
J Cell Sci; 2006 Aug; 119(Pt 16):3284-95. PubMed ID: 16868026
[TBL] [Abstract][Full Text] [Related]
25. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras.
Pearson M; Carbone R; Sebastiani C; Cioce M; Fagioli M; Saito S; Higashimoto Y; Appella E; Minucci S; Pandolfi PP; Pelicci PG
Nature; 2000 Jul; 406(6792):207-10. PubMed ID: 10910364
[TBL] [Abstract][Full Text] [Related]
26. PML is induced by oncogenic ras and promotes premature senescence.
Ferbeyre G; de Stanchina E; Querido E; Baptiste N; Prives C; Lowe SW
Genes Dev; 2000 Aug; 14(16):2015-27. PubMed ID: 10950866
[TBL] [Abstract][Full Text] [Related]
27. PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR.
Bernardi R; Guernah I; Jin D; Grisendi S; Alimonti A; Teruya-Feldstein J; Cordon-Cardo C; Simon MC; Rafii S; Pandolfi PP
Nature; 2006 Aug; 442(7104):779-85. PubMed ID: 16915281
[TBL] [Abstract][Full Text] [Related]
28. Role of the promyelocytic leukemia body in the dynamic interaction between the androgen receptor and steroid receptor coactivator-1 in living cells.
Rivera OJ; Song CS; Centonze VE; Lechleiter JD; Chatterjee B; Roy AK
Mol Endocrinol; 2003 Jan; 17(1):128-40. PubMed ID: 12511612
[TBL] [Abstract][Full Text] [Related]
29. ZNF198, a zinc finger protein rearranged in myeloproliferative disease, localizes to the PML nuclear bodies and interacts with SUMO-1 and PML.
Kunapuli P; Kasyapa CS; Chin SF; Caldas C; Cowell JK
Exp Cell Res; 2006 Nov; 312(19):3739-51. PubMed ID: 17027752
[TBL] [Abstract][Full Text] [Related]
30. PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia.
Boddy MN; Howe K; Etkin LD; Solomon E; Freemont PS
Oncogene; 1996 Sep; 13(5):971-82. PubMed ID: 8806687
[TBL] [Abstract][Full Text] [Related]
31. Human fibroblasts require the Rb family of tumor suppressors, but not p53, for PML-induced senescence.
Mallette FA; Goumard S; Gaumont-Leclerc MF; Moiseeva O; Ferbeyre G
Oncogene; 2004 Jan; 23(1):91-9. PubMed ID: 14712214
[TBL] [Abstract][Full Text] [Related]
32. Selective activation of NFAT by promyelocytic leukemia protein.
Lo YH; Wu CC; Shih HM; Lai MZ
Oncogene; 2008 Jun; 27(27):3821-30. PubMed ID: 18246125
[TBL] [Abstract][Full Text] [Related]
33. The key role of PML in IFN-α induced cellular senescence of human mesenchymal stromal cells.
Fu S; Wei J; Wang G; Wang B; Wang Y; Lai X; Huang H
Int J Oncol; 2015 Jan; 46(1):351-9. PubMed ID: 25354534
[TBL] [Abstract][Full Text] [Related]
34. Nuclear DNA helicase II is recruited to IFN-alpha-activated transcription sites at PML nuclear bodies.
Fuchsová B; Novák P; Kafková J; Hozák P
J Cell Biol; 2002 Aug; 158(3):463-73. PubMed ID: 12163469
[TBL] [Abstract][Full Text] [Related]
35. Promyelocytic leukemia protein PML inhibits Nur77-mediated transcription through specific functional interactions.
Wu WS; Xu ZX; Ran R; Meng F; Chang KS
Oncogene; 2002 May; 21(24):3925-33. PubMed ID: 12032831
[TBL] [Abstract][Full Text] [Related]
36. Coiled-coil domain of PML is essential for the aberrant dynamics of PML-RARalpha, resulting in sequestration and decreased mobility of SMRT.
Huang Y; Qiu J; Chen G; Dong S
Biochem Biophys Res Commun; 2008 Jan; 365(2):258-65. PubMed ID: 17991421
[TBL] [Abstract][Full Text] [Related]
37. Dynamic nuclear localization of the baculovirus proteins IE2 and PE38 during the infection cycle: the promyelocytic leukemia protein colocalizes with IE2.
Murges D; Quadt I; Schröer J; Knebel-Mörsdorf D
Exp Cell Res; 2001 Apr; 264(2):219-32. PubMed ID: 11262179
[TBL] [Abstract][Full Text] [Related]
38. Demonstration of a RNA-dependent nuclear interaction between the promyelocytic leukaemia protein and glyceraldehyde-3-phosphate dehydrogenase.
Carlile GW; Tatton WG; Borden KL
Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):691-6. PubMed ID: 9794812
[TBL] [Abstract][Full Text] [Related]
39. [Promyelocytic leukaemia protein and defect in transforming growth factor-beta signal pathway in acute promyelocytic leukaemia].
Fuchs O; Provazníková D; Peslová G
Cas Lek Cesk; 2005; 144(2):90-4. PubMed ID: 15807293
[TBL] [Abstract][Full Text] [Related]
40. THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies.
Roussigne M; Cayrol C; Clouaire T; Amalric F; Girard JP
Oncogene; 2003 Apr; 22(16):2432-42. PubMed ID: 12717420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
